Sandra Zazo
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
Papers in
- Oncology 32
- HER2/EGFR in Cancer Research 8
- Colorectal Cancer Treatments and Studies 7
- Peptidase Inhibition and Analysis 5
-
- MicroRNA in disease regulation 5
- Co-authors
- Federico RojoJuan Madoz‐GúrpideJesús García‐FoncillasJoan AlbanellAna RoviraIon CristóbalPîlar ErolesAňa Lluch
- Journals
- Cancers (8 papers)Journal of Clinical Oncology (5 papers)Annals of Oncology (4 papers)International Journal of Molecular Sciences (4 papers)Molecular Cancer Therapeutics (3 papers)
- Partner nations
- SpainUnited StatesSweden
In The Last Decade
Sandra Zazo
54 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 383
- Oncology 564
- Molecular Biology 860
- Pathology and Forensic Medicine 125
- Hepatology 48
Countries citing papers authored by Sandra Zazo
This map shows the geographic impact of Sandra Zazo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Zazo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Zazo more than expected).
Fields of papers citing papers by Sandra Zazo
This network shows the impact of papers produced by Sandra Zazo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Zazo. The network helps show where Sandra Zazo may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Zazo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 16 | |
| 4 | 2022 | 12 | |
| 5 | 2021 | 3 | |
| 6 | 2020 | 24 | |
| 7 | 2020 | 1 | |
| 8 | 2019 | 71 | |
| 9 | 2018 | 3 | |
| 10 | 2016 | 12 | |
| 11 | 2016 | 22 | |
| 12 | 2014 | 61 | |
| 13 | 2014 | 104 | |
| 14 | 2014 | 22 | |
| 15 | 2014 | 24 | |
| 16 | 2014 | 21 | |
| 17 | 2013 | 107 | |
| 18 | 2013 | 10 | |
| 19 | 2012 | 1 | |
| 20 | 2011 | 151 |
About Sandra Zazo
Sandra Zazo is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 58 papers that have together received 1.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Lung Cancer Treatments and Mutations (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Genetic factors in colorectal cancer (7 papers), Colorectal Cancer Treatments and Studies (7 papers), MicroRNA in disease regulation (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Cancer Research (383 citations), Oncology (564 citations), Molecular Biology (860 citations), Pathology and Forensic Medicine (125 citations) and Hepatology (48 citations). Sandra Zazo has collaborated with scholars based in Spain, United States and Sweden. Frequent co-authors include Federico Rojo, Juan Madoz‐Gúrpide, Jesús García‐Foncillas, Joan Albanell, Ana Rovira, Ion Cristóbal, Pîlar Eroles, Aňa Lluch, Cristina Caramés and Sílvia Menéndez. Their work appears in journals such as Cancers, Journal of Clinical Oncology, Annals of Oncology, International Journal of Molecular Sciences and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.